Altered Central Sensitization and Pain Modulation in the CNS in Chronic Joint Pain

Current Osteoporosis Reports

Volumn 13, Issue 4, 2015, Pages 225-234

  Arendt Nielsen, Lars ^a   Skou, Søren T ^a,b,c   Nielsen, Thomas A ^a   Petersen, Kristian K ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Central mechanisms; Osteoarthrosis; Pain assessment; Spreading sensitization

Indexed keywords

ANALGESIA; ARTHRALGIA; CENTRAL NERVOUS SYSTEM SENSITIZATION; HUMAN; METABOLISM; OSTEOARTHRITIS; PAIN MEASUREMENT; PHYSIOLOGY; PROCEDURES;

ARTHRALGIA; CENTRAL NERVOUS SYSTEM SENSITIZATION; HUMANS; OSTEOARTHRITIS; PAIN MANAGEMENT; PAIN MEASUREMENT;

EID: 84934437916     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-015-0276-x     Document Type: Review

References (125)

1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96. This paper highlights the problem of living with musculoskeletal pain problems including joint pain. As compared with many other diseases, musculoskeletal pain has a significantly negative impact on the quality of life.
2. Davis MA, Ettinger WH, Neuhaus JM, Barclay JD, Segal MR. Correlates of knee pain among US adults with and without radiographic knee osteoarthritis. J Rheumatol. 1992;19(12):1943–9.
3. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27(6):1513–7.
4. Neogi T, Felson D, Niu J, et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ. 2009;339:b2844. doi:10.1136/bmj.b2844.
5. Skou ST, Thomsen H, Simonsen OH. The value of routine radiography in patients with knee osteoarthritis consulting primary health care: a study of agreement. Eur J Gen Pract. 2014;20(1):10–6.
6. Foong YC, Khan HI, Blizzard L, et al. The clinical significance, natural history and predictors of bone marrow lesion change over eight years. Arthritis Res Ther. 2014;16(4):R149.
7. Stefanik JJ, Gross KD, Guermazi A et al. The relation of MRI-detected structural damage in the medial and lateral patellofemoral joint to knee pain: the Multicenter and Framingham Osteoarthritis Studies. Osteoarthritis Cartilage. 2015;14(10):565–70.
8. Kim IJ, Kim DH, Jung JY, et al. Association between bone marrow lesions detected by magnetic resonance imaging and knee pain in community residents in Korea. Osteoarthritis Cartilage. 2013;21(9):1207–13.
9. Finan PH, Buenaver LF, Bounds SC. Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis Rheum. 2013;65(2):363–72. This paper focuses on the important aspect of profiling and subgrouping patients with knee osteoarthritis pain. A specific group with mild to moderate joint damage, but high pain seems to be a particularly sensitized group of patients.
10. Arendt-Nielsen L, Eskehave TN, Egsgaard LL, et al. Association between experimental pain biomarkers and serologic markers in patients with different degrees of painful knee osteoarthritis. Arthritis Rheum. 2014;66(12):3317–26.
11. Arendt-Nielsen L, Egsgaard LL, Petersen KK, et al. A mechanism-based pain sensitivity index to characterize knee osteoarthritis patients with different disease stages and pain levels. Eur J Pain. 2014. doi:10.1002/ejp.651. This paper shows the lack of association between joint damage and pain sensitisation in painful knee OA. A specific sensitivity index was developed with the aim to profile and subgroup patients. This may help to optimise pain management and profile patients prior to joint replacement surgery.
12. Petersen KK, Arendt-Nielsen L, Simonsen O, Wilder-Smith O, Laursen MB. Presurgical assessment of temporal summation of pain predicts the development of chronic postoperative pain 12 months after total knee replacement. Pain. 2015;156(1):55–61. This paper utilises quantitative pain assessment tools to profile knee OA patients prior to knee joint replacement. Patients developing chronic pain after knee surgery have a more pre-operative sensitization as assessed by facilitated temporal summation.
13. Petersen KK, Simonsen O, Laursen MB, Nielsen TA, Rasmussen S, Arendt-Nielsen L. Chronic postoperative pain after primary and revision total knee arthroplasty. Clin J Pain. 2015;31(1):1–6.
14. Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2(1):e000435. It has become more and more evident that many patients continue to suffer from chronic pain after an otherwise successful knee or hip replacement. The proportion of patients continuing to suffer from pain after knee replacement is higher than after hip replacement.
15. Wilson DR, McWalter EJ, Johnston JD. The measurement of joint mechanics and their role in osteoarthritis genesis and progression. Med Clin N Am. 2009;93(1):67–82.
16. Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013;21(1):10–5.
17. Garnero P, Aronstein WS, Cohen SB, et al. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. Osteoarthritis Cartilage. 2008;16(6):660–6.
18. Dai J, Ikegawa S. Recent advances in association studies of osteoarthritis susceptibility genes. J Hum Genet. 2010;55(2):77–80.
19. Read SJ, Dray A. Osteoarthritic pain: a review of current, theoretical and emerging therapeutics. Expert Opin Investig Drugs. 2008;17(5):619–40.
20. Dieppe PA. Relationship between symptoms and structural change in osteoarthritis: what are the important targets for therapy? J Rheumatol. 2005;32(6):1147–9.
21. Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005;17(5):624–8.
22. Lanyon P, O’Reilly S, Jones A, Doherty M. Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space. Ann Rheum Dis. 1998;57(10):595–601.
23. Suri S, Gill SE, de Massena CS, Wilson D, McWilliams DF, Walsh DA. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis. 2007;66(11):1423–8.
24. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain. 1993;54(3):241–89.
25. Neugebauer V, Schaible HG. Evidence for a central component in the sensitization of spinal neurons with joint input during development of acute arthritis in cat’s knee. J Neurophysiol. 1990;64(1):299–311.
26. Martindale JC, Wilson AW, Reeve AJ, Chessell IP, Headley PM. Chronic secondary hypersensitivity of dorsal horn neurones following inflammation of the knee joint. Pain. 2007;133(1-3):79–86.
27. Imamura M, Imamura ST, Kaziyama HH, et al. Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum. 2008;59(10):1424–31.
28. Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149(3):573–81.
29. Suokas AK, Walsh DA, McWilliams DF, et al. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2012;20(10):1075–85.
30. Lluch E, Torres R, Nijs J, Van OJ. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain. 2014;18(10):1367–75. Recent years experimental and clinical pain studies have shown that patients with chronic pain develop various pain hypersensitivity phenomena. These phenomena can be mediated by peripheral or central changes in the nervous system, and treating such mechanisms seems an important feature of pain management in painful knee OA.
31. Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010;6(10):599–606.
32. Graven-Nielsen T, Wodehouse T, Langford RM, Arendt-Nielsen L, Kidd BL. Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement. Arthritis Rheum. 2012;64(9):2907–16.
33. Skou ST, Graven-Nielsen T, Lengsoe L, Simonsen O, Laursen MB, Arendt-Nielsen L. Relating clinical measures of pain with experimentally assessed pain mechanisms in patients with knee osteoarthritis. Scand J Pain. 2013;4(2):111–7.
34. Arendt-Nielsen L, Graven-Nielsen T. Translational musculoskeletal pain research. Best Pract Res Clin Rheumatol. 2011;25(2):209–26.
35. Bajaj P, Bajaj P, Graven-Nielsen T, Arendt-Nielsen L. Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain. 2001;93(2):107–14.
36. Egsgaard LL, Eskehave TN, Bay-Jensen AC, Hoeck HC, Arendt-Nielsen L. Identifying specific profiles in patients with different degrees of painful knee osteoarthritis based on serological biochemical and mechanistic pain biomarkers: a diagnostic approach based on cluster analysis. Pain. 2015;156(1):96–107.
37. Lee YC, Lu B, Bathon JM, et al. Pain sensitivity and pain reactivity in osteoarthritis. Arthritis Care Res (Hoboken). 2011;63(3):320–7.
38. Kosek E, Roos EM, Ageberg E, Nilsdotter A. Increased pain sensitivity but normal function of exercise induced analgesia in hip and knee osteoarthritis–treatment effects of neuromuscular exercise and total joint replacement. Osteoarthritis Cartilage. 2013;21(9):1299–307.
39. Wylde V, Palmer S, Learmonth ID, Dieppe P. Somatosensory abnormalities in knee OA. Rheumatology (Oxford). 2012;51(3):535–43.
40. Thompson LR, Boudreau R, Newman AB, et al. The association of osteoarthritis risk factors with localized, regional and diffuse knee pain. Osteoarthritis Cartilage. 2010;18(10):1244–9.
41. Arendt-Nielsen L, Fernandez-de-Las-Penas C, Graven-Nielsen T. Basic aspects of musculoskeletal pain: from acute to chronic pain. J Man Manip Ther. 2011;19(4):186–93.
42. Laursen RJ, Graven-Nielsen T, Jensen TS, Arendt-Nielsen L. Referred pain is dependent on sensory input from the periphery: a psychophysical study. Eur J Pain. 1997;1(4):261–9.
43. Kavchak AJ, Fernandez-de-Las-Penas C, Rubin LH, et al. Association between altered somatosensation, pain, and knee stability in patients with severe knee osteoarthrosis. Clin J Pain. 2012;28(7):589–94.
44. Kosek E, Ordeberg G. Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment. Eur J Pain. 2000;4(3):229–38.
45. Farrell MJ, Gibson SJ, McMeeken JM, Helme RD. Increased movement pain in osteoarthritis of the hands is associated with A beta-mediated cutaneous mechanical sensitivity. J Pain. 2000;1(3):229–42.
46. Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID’s: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain. 2001;91(1-2):23–31.
47. Skou ST, Graven-Nielsen T, Rasmussen S, Simonsen OH, Laursen MB, Arendt-Nielsen L. Facilitation of pain sensitization in knee osteoarthritis and persistent post-operative pain: a cross-sectional study. Eur J Pain. 2014;18(7):1024–31.
48. Lundblad H, Kreicbergs A, Jansson KA. Prediction of persistent pain after total knee replacement for osteoarthritis. J Bone Joint Surg (Br). 2008;90(2):166–71.
49. Hendiani JA, Westlund KN, Lawand N, Goel N, Lisse J, McNearney T. Mechanical sensation and pain thresholds in patients with chronic arthropathies. J Pain. 2003;4(4):203–11.
50. Goodin BR, Glover TL, Sotolongo A, et al. The association of greater dispositional optimism with less endogenous pain facilitation is indirectly transmitted through lower levels of pain catastrophizing. J Pain. 2013;14(2):126–35.
51. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain. 2000;88(1):69–78.
52. Arendt-Nielsen L, Yarnitsky D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J Pain. 2009;10(6):556–72.
53. Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev. 2004;46(3):295–309.
54. Arendt-Nielsen L, Sluka KA, Nie HL. Experimental muscle pain impairs descending inhibition. Pain. 2008;140(3):465–71.
55. King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley III JL. Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain. 2009;143(3):172–8.
56. Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114(1-2):295–302.
57. Skou ST, Graven-Nielsen T, Rasmussen S, Simonsen OH, Laursen MB, Arendt-Nielsen L. Widespread sensitization in patients with chronic pain after revision total knee arthroplasty. Pain. 2013;154(9):1588–94.
58. Sandrini G, Rossi P, Milanov I, Serrao M, Cecchini AP, Nappi G. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia. 2006;26(7):782–9.
59. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states–maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25(2):141–54.
60. Chappell AS, Desaiah D, Liu-Seifert H, et al. A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract. 2011;11(1):33–41.
61. Chappell AS, Ossanna MJ, Liu-Seifert H, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain. 2009;146(3):253–60.
62. Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138(1):22–8.
63. Martel MO, Wasan AD, Edwards RR. Sex differences in the stability of conditioned pain modulation (CPM) among patients with chronic pain. Pain Med. 2013;14(11):1757–68.
64. Sorensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L. Hyperexcitability in fibromyalgia. J Rheumatol. 1998;25(1):152–5.
65. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Giani C, Zbinden AM, Radanov BP. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain. 2001;17(4):306–15.
66. Graven-Nielsen T, Aspegren KS, Henriksson KG, et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain. 2000;85(3):483–91.
67. Weissman-Fogel I, Granovsky Y, Crispel Y, et al. Enhanced presurgical pain temporal summation response predicts post-thoracotomy pain intensity during the acute postoperative phase. J Pain. 2009;10(6):628–36.
68. Buvanendran A, Kroin JS, Della Valle CJ, Kari M, Moric M, Tuman KJ. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial. Anesth Analg. 2010;110(1):199–207.
69. Niesters M, Hoitsma E, Sarton E, Aarts L, Dahan A. Offset analgesia in neuropathic pain patients and effect of treatment with morphine and ketamine. Anesthesiology. 2011;115(5):1063–71.
70. King CD. Conditioned pain modulation and offset analgesia: different avenues to inhibit pain. Pain. 2014;155(12):2444–5.
71. Grill JD, Coghill RC. Transient analgesia evoked by noxious stimulus offset. J Neurophysiol. 2002;87(4):2205–8.
72. Yelle MD, Rogers JM, Coghill RC. Offset analgesia: a temporal contrast mechanism for nociceptive information. Pain. 2008;134(1-2):174–86.
73. Derbyshire SW, Osborn J. Enhancement of offset analgesia during sequential testing. Eur J Pain. 2008;12(8):980–9.
74. Derbyshire SW, Osborn J. Offset analgesia is mediated by activation in the region of the periaqueductal grey and rostral ventromedial medulla. Neuroimage. 2009;47(3):1002–6.
75. Yelle MD, Oshiro Y, Kraft RA, Coghill RC. Temporal filtering of nociceptive information by dynamic activation of endogenous pain modulatory systems. J Neurosci. 2009;29(33):10264–71.
76. Niesters M, Dahan A, Swartjes M, et al. Effect of ketamine on endogenous pain modulation in healthy volunteers. Pain. 2011;152(3):656–63.
77. Niesters M, Proto PL, Aarts L, Sarton EY, Drewes AM, Dahan A. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth. 2014;113(1):148–56.
78. Martucci KT, Eisenach JC, Tong C, Coghill RC. Opioid-independent mechanisms supporting offset analgesia and temporal sharpening of nociceptive information. Pain. 2012;153(6):1232–43.
79. Suzan E, Treister R, Pud D, Haddad M, Eisenberg E. The effect of hydromorphone therapy on psychophysical measurements of the descending inhibitory pain systems in patients with chronic radicular pain. Pain Med. 2015;16(1):168–75.
80. Martucci KT, Yelle MD, Coghill RC. Differential effects of experimental central sensitization on the time-course and magnitude of offset analgesia. Pain. 2012;153(2):463–72.
81. Naugle KM, Cruz-Almeida Y, Fillingim RB, Riley III JL. Offset analgesia is reduced in older adults. Pain. 2013;154(11):2381–7.
82. Ruscheweyh R, Kuhnel M, Filippopulos F, Blum B, Eggert T, Straube A. Altered experimental pain perception after cerebellar infarction. Pain. 2014;155(7):1303–12.
83. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 2000;93(4):1123–33.
84. Sarzi-Puttini P, Atzeni F, Mease PJ. Chronic widespread pain: from peripheral to central evolution. Best Pract Res Clin Rheumatol. 2011;25(2):133–9.
85. Atzeni F, Cazzola M, Benucci M, Di FM, Salaffi F, Sarzi-Puttini P. Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol. 2011;25(2):165–71.
86. Mourao AF, Blyth FM, Branco JC. Generalised musculoskeletal pain syndromes. Best Pract Res Clin Rheumatol. 2010;24(6):829–40.
87. Shenker N, Haigh R, Roberts E, Mapp P, Harris N, Blake D. A review of contralateral responses to a unilateral inflammatory lesion. Rheumatology (Oxford). 2003;42(11):1279–86.
88. Sang CN, Gracely RH, Max MB, Bennett GJ. Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism. Anesthesiology. 1996;85(3):491–6.
89. Shenker NG, Haigh RC, Mapp PI, Harris N, Blake DR. Contralateral hyperalgesia and allodynia following intradermal capsaicin injection in man. Rheumatology (Oxford). 2008;47(9):1417–21.
90. Gerber RK, Nie H, Arendt-Nielsen L, Curatolo M, Graven-Nielsen T. Local pain and spreading hyperalgesia induced by intramuscular injection of nerve growth factor are not reduced by local anesthesia of the muscle. Clin J Pain. 2011;27(3):240–7.
91. Andersen H, Arendt-Nielsen L, Svensson P, Danneskiold-Samsoe B, Graven-Nielsen T. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans. Exp Brain Res. 2008;191(3):371–82.
92. Schabrun SM, Christensen SW, Mrachacz-Kersting N, Graven-Nielsen T. Motor cortex reorganization and impaired function in the transition to sustained muscle pain. Cereb Cortex. 2015;bhu319.
93. Veldman PH, Goris RJ. Multiple reflex sympathetic dystrophy. Which patients are at risk for developing a recurrence of reflex sympathetic dystrophy in the same or another limb. Pain. 1996;64(3):463–6.
94. Kozin F, McCarty DJ, Sims J, Genant H. The reflex sympathetic dystrophy syndrome. I. Clinical and histologic studies: evidence for bilaterality, response to corticosteroids and articular involvement. Am J Med. 1976;60(3):321–31.
95. Konopka KH, Harbers M, Houghton A, et al. Bilateral sensory abnormalities in patients with unilateral neuropathic pain; a quantitative sensory testing (QST) study. PLoS One. 2012;7(5):e37524.
96. Malan TP, Ossipov MH, Gardell LR, et al. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain. 2000;86(1-2):185–94.
97. Malenfant A, Forget R, Amsel R, Papillon J, Frigon JY, Choiniere M. Tactile, thermal and pain sensibility in burned patients with and without chronic pain and paresthesia problems. Pain. 1998;77(3):241–51.
98. Fillingim RB, Fillingim LA, Hollins M, Sigurdsson A, Maixner W. Generalized vibrotactile allodynia in a patient with temporomandibular disorder. Pain. 1998;78(1):75–8.
99. John MT, Miglioretti DL, LeResche L, Von KM, Critchlow CW. Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain. Pain. 2003;102(3):257–63.
100. Fernandez-de-Las-Penas C, Galan-del-Rio F, Ortega-Santiago R, Jimenez-Garcia R, Arendt-Nielsen L, Svensson P. Bilateral thermal hyperalgesia in trigeminal and extra-trigeminal regions in patients with myofascial temporomandibular disorders. Exp Brain Res. 2010;202(1):171–9.
101. Zakrzewska JM. Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain. 2013;14(1):37.
102. de Goeij M, van Eijk LT, Vanelderen P, et al. Systemic inflammation decreases pain threshold in humans in vivo. PLoS One. 2013;8(12):e84159.
103. Hutchinson MR, Buijs M, Tuke J, et al. Low-dose endotoxin potentiates capsaicin-induced pain in man: evidence for a pain neuroimmune connection. Brain Behav Immun. 2013;30:3–11.
104. Morris VH, Cruwys SC, Kidd BL. Characterisation of capsaicin-induced mechanical hyperalgesia as a marker for altered nociceptive processing in patients with rheumatoid arthritis. Pain. 1997;71(2):179–86.
105. Morris V, Cruwys S, Kidd B. Increased capsaicin-induced secondary hyperalgesia as a marker of abnormal sensory activity in patients with fibromyalgia. Neurosci Lett. 1998;250(3):205–7.
106. Lapossy E, Maleitzke R, Hrycaj P, Mennet W, Muller W. The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol. 1995;24(1):29–33.
107. Holm LW, Carroll LJ, Cassidy JD, Skillgate E, Ahlbom A. Widespread pain following whiplash-associated disorders: incidence, course, and risk factors. J Rheumatol. 2007;34(1):193–200.
108. Macfarlane GJ. Generalized pain, fibromyalgia and regional pain: an epidemiological view. Baillieres Best Pract Res Clin Rheumatol. 1999;13(3):403–14.
109. Smith SB, Maixner DW, Fillingim RB, et al. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum. 2012;64(2):584–93.
110. Smith SB, Maixner DW, Greenspan JD, et al. Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. J Pain. 2011;12(11 Suppl):T92–101.
111. Farrell M, Gibson S, McMeeken J, Helme R. Pain and hyperalgesia in osteoarthritis of the hands. J Rheumatol. 2000;27(2):441–7.
112. Xu YM, Ge HY, Arendt-Nielsen L. Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain. 2010;11(12):1348–55.
113. O’Neill S, Manniche C, Graven-Nielsen T, Arendt-Nielsen L. Generalized deep-tissue hyperalgesia in patients with chronic low-back pain. Eur J Pain. 2007;11(4):415–20.
114. O’Neill S, Graven-Nielsen T, Manniche C, Arendt-Nielsen L. Ultrasound guided, painful electrical stimulation of lumbar facet joint structures: an experimental model of acute low back pain. Pain. 2009;144(1-2):76–83.
115. Koelbaek JM, Graven-Nielsen T, Schou OA, Arendt-Nielsen L. Generalised muscular hyperalgesia in chronic whiplash syndrome. Pain. 1999;83(2):229–34.
116. Scott D, Jull G, Sterling M. Widespread sensory hypersensitivity is a feature of chronic whiplash-associated disorder but not chronic idiopathic neck pain. Clin J Pain. 2005;21(2):175–81.
117. Schneider GM, Smith AD, Hooper A, et al. Minimizing the source of nociception and its concurrent effect on sensory hypersensitivity: an exploratory study in chronic whiplash patients. BMC Musculoskelet Disord. 2010;11:29. doi:10.1186/1471-2474-11-29.
118. Herren-Gerber R, Weiss S, Arendt-Nielsen L, et al. Modulation of central hypersensitivity by nociceptive input in chronic pain after whiplash injury. Pain Med. 2004;5(4):366–76.
119. Bajaj P, Graven-Nielsen T, Arendt-Nielsen L. Trigger points in patients with lower limb osteoarthritis. J Musculoskel Pain. 2001;9(3):17–33.
120. Carli G, Suman AL, Biasi G, Marcolongo R. Reactivity to superficial and deep stimuli in patients with chronic musculoskeletal pain. Pain. 2002;100(3):259–69.
121. Banic B, Petersen-Felix S, Andersen OK, et al. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain. 2004;107(1-2):7–15.
122. Leblebici B, Pektas ZO, Ortancil O, Hurcan EC, Bagis S, Akman MN. Coexistence of fibromyalgia, temporomandibular disorder, and masticatory myofascial pain syndromes. Rheumatol Int. 2007;27(6):541–4.
123. Balasubramaniam R, Zhu H, Nickerson RB, Okeson JP, Carlson CR. Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):204–16.
124. Laursen BS, Bajaj P, Olesen AS, Delmar C, Arendt-Nielsen L. Health related quality of life and quantitative pain measurement in females with chronic non-malignant pain. Eur J Pain. 2005;9(3):267–75.
125. Burstein R, Jakubowski M, Garcia-Nicas E, et al. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol. 2010;68(1):81–91.